已收盘 02-06 16:00:00 美东时间
+0.160
+7.02%
今日重点评级关注:韦德布什:维持Replimune Group"跑赢大市"评级,目标价从18美元升至19美元;巴克莱:维持CytomX Therapeutics"超配"评级,目标价从8美元升至10美元
02-05 11:28
D. Boral Capital analyst Jason Kolbert maintains Nano X Imaging (NASDAQ:NNOX) with a Buy and lowers the price target from $8 to $5.
02-04 20:44
FDA approves Nanox's TAP2D capability, enhancing digital tomosynthesis systems by providing 2D views alongside 3D scans, reducing radiation and costs while improving diagnostic accuracy. This marks a key step toward Nanox's aim of making its systems standalone primary imaging solutions in the U.S., as they are in Europe. The update emphasizes Nanox's commitment to innovation and accessibility, building on its AI-driven, cloud-based platform to re...
02-03 13:15
ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD. VANCOUVER, BC, Jan. 27, 2026 /PRNewswire/ -- USANewsGroup.com News Commentary – The global medical imaging market hit a massive $45.5 billion...
01-27 23:14
Althea France, part of one of Europe's largest independent medical technology services providers, to distribute CE-marked Nanox.ARC system across French healthcare sectorPartnership represents Nanox's fourth
2025-11-25 21:13
NANO-X IMAGING (NNOX) has announced a stock offering to raise gross proceeds of approximately $15 million. The medical imaging technology company entered into a securities purchase agreement with a si...
2025-11-24 17:17
Nanox Imaging Ltd. announced a securities purchase agreement with a single institutional investor for 3,826,530 ordinary shares, expected to raise approximately $15 million. Proceeds will be used for working capital and growth initiatives, including technology advancements, market expansion, and AI infrastructure. The offering is being handled by Titan Partners Group. The company aims to enhance its medical imaging solutions and improve accessibi...
2025-11-24 04:26
Companies Reporting Before The Bell • Atkore (NYSE:ATKR) is likely to report qu...
2025-11-20 19:11
今日重点评级关注:Oppenheimer:维持Olema Pharmaceuticals"跑赢大市"评级,目标价从22美元升至45美元;Bernstein:维持Atlassian"跑赢大市"评级,目标价从290美元升至304美元
2025-11-19 11:01